Unraveling pancreatic islet biology by quantitative proteomics

References

• Elayat AA, el-Naggar MM, Tahir M. An immunocytochemical and morphometric study of the rat pancreatic islets. J. Anat.186(Pt 3), 629–637 (1995).
   PubMed Web of Science ®Google Scholar
• Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl Acad. Sci. USA103(7), 2334–2339 (2006).
   PubMed Web of Science ®Google Scholar
• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β cell deficit and increased β-cell apoptosis in humans with Type 2 diabetes. Diabetes5(1), 102–110 (2003).
   Google Scholar
• Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ175(2), 165–170 (2006).
   PubMed Web of Science ®Google Scholar
• Meisterfeld R, Ehehalt F, Saeger HD, Solimena M. Pancreatic disorders and diabetes mellitus. Exp. Clin. Endocrinol. Diabetes116(Suppl. 1), S7–S12 (2008).
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin. Invest.115(5), 1111–1119 (2005).
   PubMed Web of Science ®Google Scholar
• Diakogiannaki E, Dhayal S, Childs CE, Calder PC, Welters HJ, Morgan NG. Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic β-cells. J. Endocrinol.194(2), 283–291 (2007).
   Google Scholar
• El-Assaad W, Buteau J, Peyot ML et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology144(9), 4154–4163 (2003).
   PubMed Web of Science ®Google Scholar
• Federici M, Hribal M, Perego L et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes50(6), 1290–1301 (2001).
   PubMed Web of Science ®Google Scholar
• Guardado-Mendoza R, Davalli AM, Chavez AO et al. Pancreatic islet amyloidosis, β-cell apoptosis and α-cell proliferation are determinants of islet remodeling in Type-2 diabetic baboons. Proc. Natl Acad. Sci. USA106(33), 13992–13997 (2009).
   PubMed Web of Science ®Google Scholar
• Di Cairano ES, Davalli AM, Perego L et al. The glial glutamate transporter 1 (GLT1) is expressed by pancreatic β-cells and prevents glutamate-induced β-cell death. J Biol. Chem.286(16), 14007–14018 (2011).
   Google Scholar
• Hribal ML, Tornei F, Pujol A et al. Transgenic mice overexpressing human G97 R IRS-1 show impaired insulin action and insulin secretion. J Cell Mol. Med.12(5B), 2096–2106 (2008).
   Google Scholar
• Metz TO, Jacobs JM, Gritsenko MA et al. Characterization of the human pancreatic islet proteome by 2D LC/MS/MS. J Proteome Res.5(12), 3345–3354 (2006).
   PubMed Web of Science ®Google Scholar
• Petyuk VA, Qian WJ, Hinault C et al. Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues. J. Proteome Res.7(8), 3114–3126 (2008).
   Google Scholar
• Han D, Moon S, Kim H et al. Detection of differential proteomes associated with the development of Type 2 diabetes in the Zucker rat model using the iTRAQ technique. J Proteome Res.10(2), 564–577 (2010).
   Google Scholar
• Waanders LF, Chwalek K, Monetti M, Kumar C, Lammert E, Mann M. Quantitative proteomic analysis of single pancreatic islets. Proc. Natl Acad. Sci. USA106(45), 18902–18907 (2009).
   PubMed Web of Science ®Google Scholar
• Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The identification of potential factors associated with the development of Type 2 diabetes: a quantitative proteomics approach. Mol. Cell. Proteomics7(8), 1434–1451 (2008).
   PubMedGoogle Scholar
• Hong OK, Suh SH, Kwon HS et al. Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayers. J. Cell Biochem.95(4), 769–781 (2005).
   Google Scholar
• Dowling P, O’Driscoll L, O’Sullivan F et al. Proteomic screening of glucose-responsive and glucose nonresponsive MIN-6 β cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress. Proteomics6(24), 6578–6587 (2006).
   Google Scholar
• Maziarz M, Chung C, Drucker DJ, Emili A. Integrating global proteomic and genomic expression profiles generated from islet α cells: opportunities and challenges to deriving reliable biological inferences. Mol. Cell. Proteomics4(4), 458–474 (2005).
   Google Scholar
• D’Hertog W, Overbergh L, Lage K et al. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol. Cell. Proteomics6(12), 2180–2199 (2007).
   PubMed Web of Science ®Google Scholar
• Brunner Y, Coute Y, Iezzi M et al. Proteomics analysis of insulin secretory granules. Mol. Cell. Proteomics6(6), 1007–1017 (2007).
   PubMed Web of Science ®Google Scholar
• Nyblom HK, Thorn K, Ahmed M, Bergsten P. Mitochondrial protein patterns correlating with impaired insulin secretion from INS-1E cells exposed to elevated glucose concentrations. Proteomics6(19), 5193–5198 (2006).
   PubMedGoogle Scholar
• Hickey AJ, Bradley JW, Skea GL et al. Proteins associated with immunopurified granules from a model pancreatic islet β-cell system: proteomic snapshot of an endocrine secretory granule. J. Proteome Res.8(1), 178–186 (2009).
   Google Scholar
• Ortsater H, Bergsten P. Protein profiling of pancreatic islets. Expert Rev. Proteomics3(6), 665–675 (2006).
   PubMed Web of Science ®Google Scholar
• Lopez JL. 2D electrophoresis in proteome expression analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.849(1–2), 190–202 (2007).
   PubMed Web of Science ®Google Scholar
• Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis18(11), 2071–2077 (1997).
   PubMed Web of Science ®Google Scholar
• Ahmed M. Proteomics and islet research. Adv. Exp. Med. Biol.654, 363–390 (2010).
   Google Scholar
• Sundsten T, Ortsater H. Proteomics in diabetes research. Mol. Cell Endocrinol.297(1–2), 93–103 (2009).
   PubMed Web of Science ®Google Scholar
• Maris M, Overbergh L, Mathieu C. Type 2 diabetes: gaining insight into the disease process using proteomics. Proteomics Clin. Appl.2(3), 312–326 (2008).
   Google Scholar
• Sparre T, Larsen MR, Heding PE, Karlsen AE, Jensen ON, Pociot F. Unraveling the pathogenesis of Type 1 diabetes with proteomics: present and future directions. Mol. Cell. Proteomics4(4), 441–457 (2005).
   PubMed Web of Science ®Google Scholar
• Minden JS, Dowd SR, Meyer HE, Stuhler K. Difference gel electrophoresis. Electrophoresis30(Suppl. 1), S156–S161 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SW, Hwang HJ, Baek YM, Lee SH, Hwang HS, Yun JW. Proteomic and transcriptomic analysis for streptozotocin-induced diabetic rat pancreas in response to fungal polysaccharide treatments. Proteomics8(11), 2344–2361 (2008).
   Google Scholar
• Jagerbrink T, Lexander H, Palmberg C et al. Differential protein expression in pancreatic islets after treatment with an imidazoline compound. Cell. Mol. Life Sci.64(10), 1310–1316 (2007).
   Google Scholar
• Xie X, Li S, Liu S, Lu Y, Shen P, Ji J. Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection. Biochim. Biophys. Acta.1784(2), 276–284 (2008).
   Google Scholar
• Johnson JD, Bernal-Mizrachi E, Alejandro EU et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc. Natl Acad. Sci. USA103(51), 19575–19580 (2006).
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature422(6928), 198–207 (2003).
   PubMed Web of Science ®Google Scholar
• Qian WJ, Jacobs JM, Liu T, Camp DG 2nd, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics5(10), 1727–1744 (2006).
   PubMed Web of Science ®Google Scholar
• Martens GA, Jiang L, Verhaeghen K et al. Protein markers for insulin-producing β cells with higher glucose sensitivity. PLoS One5(12), e14214 (2010).
   Google Scholar
• Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem.76(14), 4193–4201 (2004).
   PubMed Web of Science ®Google Scholar
• Zhou JY, Schepmoes AA, Zhang X et al. Improved LC–MS/MS spectral counting statistics by recovering low-scoring spectra matched to confidently identified peptide sequences. J. Proteome Res.9(11), 5698–5704 (2010).
   Web of Science ®Google Scholar
• Qian WJ, Jacobs JM, Camp DG 2nd et al. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics5(2), 572–584 (2005).
   PubMed Web of Science ®Google Scholar
• Wang W, Shaler TA, Norton SM, Hill LR, Becker CH. Direct quantitative profiling of proteins in complex biological systems by nano electrospray mass spectrometry without tagging or isotopic standards. Presented at: 50th ASMS Conference on Mass Spectrometry and Allied Topics. Orlando, FL, USA, 2–6 June 2002.
   Google Scholar
• Metz TO, Qian WJ, Jacobs JM et al. Application of proteomics in the discovery of candidate protein biomarkers in a Diabetes Autoantibody Standardization Program (DASP) sample subset. J. Proteome Res.7(2), 698–707 (2008).
   PubMed Web of Science ®Google Scholar
• Smith RD anderson GA, Lipton MS et al. An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics (5), 513–523 (2002).
   Google Scholar
• Monroe ME, Tolic N, Jaitly N, Shaw JL, Adkins JN, Smith RD. VIPER: an advanced software package to support high-throughput LC–MS peptide identification. Bioinformatics3(15), 2021–2023 (2007).
   Google Scholar
• Li XJ, Yi EC, Kemp CJ, Zhang H, Aebersold R. A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry. Mol. Cell. Proteomics4(9), 1328–1340 (2005).
   PubMed Web of Science ®Google Scholar
• Jaffe JD, Mani DR, Leptos KC, Church GM, Gillette MA, Carr SA. PEPPeR, a platform for experimental proteomic pattern recognition. Mol. Cell. Proteomics5(10), 1927–1941 (2006).
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol.6(12), 1367–1137 (2008).
   Google Scholar
• Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol.1(5), 252–262 (2005).
   PubMed Web of Science ®Google Scholar
• Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1(5), 376–386 (2002).
   PubMed Web of Science ®Google Scholar
• Qian WJ, Monroe ME, Liu T et al. Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol. Cell. Proteomics4(5), 700–709 (2005).
   PubMed Web of Science ®Google Scholar
• Petritis BO, Qian WJ, Camp DG 2nd, Smith RD. A simple procedure for effective quenching of trypsin activity and prevention of 18O-labeling back-exchange. J. Proteome Res.8(5), 2157–2163 (2009).
   Google Scholar
• Qian WJ, Liu T, Petyuk VA et al. Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled ‘universal’ reference sample. J. Proteome Res.8(1), 2290–2299 (2009).
   Google Scholar
• Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3(12), 1154–1169 (2004).
   PubMed Web of Science ®Google Scholar
• Thompson A, Schafer J, Kuhn K et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem.75(8), 1895–1904 (2003).
   PubMed Web of Science ®Google Scholar
• Jin J, Park J, Kim K et al. Detection of differential proteomes of human β-cells during islet-like differentiation using iTRAQ labeling. J. Proteome Res.8(3), 1393–1403 (2009).
   PubMed Web of Science ®Google Scholar
• Pichler P, Kocher T, Holzmann J et al. Peptide labeling with isobaric tags yields higher identification rates using iTRAQ 4-plex compared with TMT 6-plex and iTRAQ 8-plex on LTQ Orbitrap. Anal. Chem.8(15), 6549–6558 (2010).
   Google Scholar
• Ahmed M, Bergsten P. Glucose-induced changes of multiple mouse islet proteins analysed by 2D gel electrophoresis and mass spectrometry. Diabetologia48(3), 477–485 (2005).
   PubMed Web of Science ®Google Scholar
• Ahmed M, Forsberg J, Bergsten P. Protein profiling of human pancreatic islets by 2D gel electrophoresis and mass spectrometry. J. Proteome Res.4(3), 931–940 (2005).
   PubMed Web of Science ®Google Scholar
• Sanchez JC, Chiappe D, Converset V et al. The mouse SWISS- D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics1(1), 136–163 (2001).
   PubMed Web of Science ®Google Scholar
• Kutlu B, Burdick D, Baxter D et al. Detailed transcriptome atlas of the pancreatic β cell. BMC Med. Genomics3 (2009).
   Google Scholar
• Collins H, Najafi H, Buettger C, Rombeau J, Settle RG, Matschinsky FM. Identification of glucose response proteins in two biological models of β-cell adaptation to chronic high glucose exposure. J. Biol. Chem.67(2), 1357–1366 (1992).
   Google Scholar
• Collins HW, Buettger C, Matschinsky F. High-resolution 2D polyacrylamide gel electrophoresis reveals a glucose-response protein of 65 kDa in pancreatic islet cells. Proc. Natl Acad. Sci. USA87(14), 5494–5498 (1990).
   PubMedGoogle Scholar
• Hu X, Friedman D, Hill S et al. Proteomic exploration of pancreatic islets in mice null for the α2A adrenergic receptor. J. Mol. Endocrinol.35(1), 73–88 (2005).
   PubMed Web of Science ®Google Scholar
• Yamada M, Ohata H, Momose K, Richelson E. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. Res. Commun. Mol. Pathol. Pharmacol.90(1), 37–47 (1995).
   Google Scholar
• Eizirik DL, Mandrup-Poulsen T. A choice of death – the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia44(12), 2115–2133 (2001).
   PubMed Web of Science ®Google Scholar
• Van Belle TL, Taylor P, von Herrath MG. Mouse models for Type 1 diabetes. Drug Discov. Today Dis. Models6(2), 41–45 (2009).
   PubMedGoogle Scholar
• Hohmeier HE, Newgard CB. Cell lines derived from pancreatic islets. Mol. Cell Endocrinol.228(1–2), 121–128 (2004).
   PubMed Web of Science ®Google Scholar
• Andersen HU, Larsen PM, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J. 2D gel electrophoresis of rat islet proteins. Interleukin 1 β-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes44(4), 400–407 (1995).
   PubMed Web of Science ®Google Scholar
• Andersen HU, Fey SJ, Larsen PM et al. Interleukin-1β induced changes in the protein expression of rat islets: a computerized database. Electrophoresis18(11), 2091–2103 (1997).
   PubMed Web of Science ®Google Scholar
• Karlsen AE, Storling ZM, Sparre T et al. Immune-mediated β-cell destruction in vitro and in vivo-A pivotal role for galectin-3. Biochem. Biophys. Res. Commun.344(1), 406–415 (2006).
   PubMedGoogle Scholar
• Zhou JY, Afjehi-Sadat L, Asress S et al. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J. Proteome Res.9(10), 5133–5141 (2010).
   PubMed Web of Science ®Google Scholar
• Karabatas LM, Pastorale C, de Bruno LF et al. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice. Pancreas30(4), 318–324 (2005).
   Google Scholar
• Qiu L, List EO, Kopchick JJ. Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell. Proteomics4(9), 1311–1318 (2005).
   Google Scholar
• Lu H, Koshkin V, Allister EM, Gyulkhandanyan AV, Wheeler MB. Molecular and metabolic evidence for mitochondrial defects associated with β-cell dysfunction in a mouse model of Type 2 diabetes. Diabetes59(2), 448–459 (2010).
   PubMedGoogle Scholar
• Sanchez JC, Converset V, Nolan A et al. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice. Mol. Cell. Proteomics1(7), 509–516 (2002).
   PubMed Web of Science ®Google Scholar
• Nyblom HK, Bugliani M, Fung E et al. Apoptotic, regenerative and immune-related signaling in human islets from Type 2 diabetes individuals. J. Proteome Res.8(12), 5650–5656 (2009).
   PubMed Web of Science ®Google Scholar
• Noguchi H. Pancreatic islet transplantation. World J Gastrointest. Surg.1(1), 16–20 (2009).
   Google Scholar
• Levetan CS, Upham LV, Deng S et al. Discovery of a human peptide sequence signaling islet neogenesis. Endocr. Pract.14(9), 1075–1083 (2008).
   PubMedGoogle Scholar
• Verges B. Effects of glitazones in the treatment of diabetes and/or hyperlipidaemia: glycaemic control and plasma lipid levels. Fundam. Clin. Pharmacol.21(Suppl. 2), 15–18 (2007).
   Google Scholar
• Yang F, Wu S, Stenoien DL et al. Combined pulsed-Q dissociation and electron transfer dissociation for identification and quantification of iTRAQ-labeled phosphopeptides. Anal. Chem.81(10), 4137–4143 (2009).
   PubMedGoogle Scholar
• Butterfield DA, Sultana R. Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders. Expert Rev. Proteomics5(2), 157–160 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou J, Livak MF, Bernier M et al. Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am. J Physiol. Endocrinol. Metab.293(2), E538–E547 (2007).
   PubMedGoogle Scholar
• Jeram SM, Srikumar T, Pedrioli PG, Raught B. Using mass spectrometry to identify ubiquitin and ubiquitin-like protein conjugation sites. Proteomics9(4), 922–934 (2009).
   PubMedGoogle Scholar
• Ehninger A, Mziaut H, Solimena M. Emerging role of SUMO in pancreatic β-cells. Horm. Metab. Res.39(9), 658–664 (2007).
   PubMed Web of Science ®Google Scholar
• Hossain M, Kaleta DT, Robinson EW et al. Enhanced sensitivity for selected reaction monitoring-mass spectrometry-based targeted proteomics using a dual-stage electrodynamic ion funnel interface. Mol. Cell. Proteomics10(2), M000062–MCP201 (2010).
   Google Scholar